Sierra Summit Advisors »

Urogen Pharma shares owned by Sierra Summit Advisors

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Sierra Summit Advisors from 13F filings

Historical chart of Sierra Summit Advisors investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Sierra Summit Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Sierra Summit Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $218k 15k 15.00

More positions owned by Sierra Summit Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Intuitive Surgical Com New (ISRG)
Lululemon Athletica (LULU)
Boston Scientific Corporation (BSX)
Meta Platforms Cl A (META)
Palo Alto Networks (PANW)
Celsius Hldgs Com New (CELH)
salesforce (CRM)
MercadoLibre (MELI)
Costco Wholesale Corporation (COST)
Visa Com Cl A (V)

View all positions for Sierra Summit Advisors

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma